An important molecular link between obesity and antitumor resistance is increased leptin secretion, which can affect the intrinsic molecular characteristics of breast cancer cells and influence the therapeutic response of patients76. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.